Accelerate Diagnostics Company Profile (NASDAQ:AXDX)

About Accelerate Diagnostics

Accelerate Diagnostics logoAccelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that improve patient outcomes and lower healthcare costs through the diagnosis of serious infections. The Company's technology platform is built to address these challenges by delivering testing of infectious pathogens in various patient sample types. The Company is focused on the development of a rapid diagnostic platform, the Accelerate ID/AST System (ID/AST System or Accelerate ID/AST System), intended for the diagnosis of infectious pathogens. The ID/AST System utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The ID/AST System features walk-away automation and consists of a fixed instrument and single-use test kit.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AXDX
  • CUSIP:
Key Metrics:
  • Previous Close: $27.01
  • 50 Day Moving Average: $23.76
  • 200 Day Moving Average: $17.03
  • 52-Week Range: $10.29 - $28.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -19.70
  • P/E Growth: -0.69
  • Market Cap: $1.39B
  • Outstanding Shares: 51,228,000
  • Beta: 1.19
Profitability:
  • Net Margins: -19,501.35%
  • Return on Equity: -58.23%
  • Return on Assets: -55.13%
Debt:
  • Current Ratio: 23.58%
  • Quick Ratio: 23.58%
Additional Links:
Companies Related to Accelerate Diagnostics:

Analyst Ratings

Consensus Ratings for Accelerate Diagnostics (NASDAQ:AXDX) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.33 (6.79% downside)

Analysts' Ratings History for Accelerate Diagnostics (NASDAQ:AXDX)
Show:
DateFirmActionRatingPrice TargetDetails
8/25/2016BTIG ResearchUpgradeNeutral -> BuyView Rating Details
8/9/2016JPMorgan Chase & Co.Boost Price TargetOverweight$17.00 -> $25.00View Rating Details
5/16/2016Piper Jaffray Cos.Reiterated RatingOverweight$25.00View Rating Details
1/29/2016William BlairReiterated RatingBuyView Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Accelerate Diagnostics (NASDAQ:AXDX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Accelerate Diagnostics (NASDAQ:AXDX)
Current Year EPS Consensus Estimate: $-1.33 EPS
Next Year EPS Consensus Estimate: $-1.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.31)($0.31)($0.31)
Q3 20161($0.32)($0.32)($0.32)
Q4 20161($0.33)($0.33)($0.33)
Q1 20171($0.33)($0.33)($0.33)
Q2 20171($0.33)($0.33)($0.33)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.31)($0.31)($0.31)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Accelerate Diagnostics (NASDAQ:AXDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Accelerate Diagnostics (NASDAQ:AXDX)
Insider Ownership Percentage: 51.40%
Institutional Ownership Percentage: 35.62%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/30/2016Jack W SchulerDirectorBuy90,147$13.95$1,257,550.65View SEC Filing  
6/14/2016Jack W SchulerDirectorBuy14,033$13.67$191,831.11View SEC Filing  
6/13/2016Jack W SchulerDirectorBuy15,967$13.70$218,747.90View SEC Filing  
6/10/2016Jack W SchulerDirectorBuy88,316$14.69$1,297,362.04View SEC Filing  
6/9/2016Jack W SchulerDirectorBuy101,272$14.14$1,431,986.08View SEC Filing  
5/20/2016Jack W SchulerDirectorBuy4,270$11.04$47,140.80View SEC Filing  
5/17/2016Jack W SchulerDirectorBuy10,000$11.45$114,500.00View SEC Filing  
5/16/2016Jack W SchulerDirectorBuy11,511$11.91$137,096.01View SEC Filing  
5/13/2016Jack W SchulerDirectorBuy20,000$12.45$249,000.00View SEC Filing  
2/9/2016Jack W SchulerDirectorBuy600,000$11.86$7,116,000.00View SEC Filing  
2/8/2016Jack W SchulerDirectorBuy20,000$12.32$246,400.00View SEC Filing  
2/5/2016Jack W SchulerDirectorBuy7,308$12.65$92,446.20View SEC Filing  
2/4/2016Jack W SchulerDirectorBuy10,000$12.98$129,800.00View SEC Filing  
2/3/2016Jack W SchulerDirectorBuy50,100$13.09$655,809.00View SEC Filing  
2/2/2016Jack W SchulerDirectorBuy20,000$13.46$269,200.00View SEC Filing  
1/21/2016Jack W SchulerDirectorBuy10,000$15.02$150,200.00View SEC Filing  
12/10/2015Larry N FeinbergMajor ShareholderBuy117,647$17.00$1,999,999.00View SEC Filing  
11/5/2015Jack W SchulerDirectorBuy11,899$16.81$200,022.19View SEC Filing  
11/4/2015Jack W SchulerDirectorBuy52,837$16.81$888,189.97View SEC Filing  
10/22/2015Jack W SchulerDirectorBuy2,160$15.82$34,171.20View SEC Filing  
9/29/2015Brink Frank Jm TenDirectorBuy9,800$15.24$149,352.00View SEC Filing  
8/26/2015Jack W SchulerDirectorBuy10,000$17.81$178,100.00View SEC Filing  
8/25/2015Jack W SchulerDirectorBuy10,000$18.56$185,600.00View SEC Filing  
4/17/2015Jack W SchulerDirectorBuy11,000$21.94$241,340.00View SEC Filing  
3/19/2015Matthew StrobeckDirectorBuy2,000$22.04$44,080.00View SEC Filing  
3/9/2015Jack W SchulerDirectorBuy22,584$17.18$387,993.12View SEC Filing  
1/5/2015Jack W SchulerDirectorBuy18,000$18.93$340,740.00View SEC Filing  
9/22/2014Jack W SchulerDirectorBuy2,588$16.44$42,546.72View SEC Filing  
9/19/2014Jack W SchulerDirectorBuy32,411$16.67$540,291.37View SEC Filing  
8/21/2014Jack W SchulerDirectorBuy2,900$16.79$48,691.00View SEC Filing  
8/5/2014Larry N FeinbergMajor ShareholderBuy11,835$15.92$188,413.20View SEC Filing  
8/5/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  
8/4/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  
7/16/2014Larry N FeinbergMajor ShareholderBuy20,000$21.54$430,800.00View SEC Filing  
7/1/2014Jack W SchulerDirectorBuy8,698$25.70$223,538.60View SEC Filing  
6/30/2014Jack W SchulerDirectorBuy10,000$26.09$260,900.00View SEC Filing  
6/30/2014Larry N FeinbergMajor ShareholderBuy20,000$25.72$514,400.00View SEC Filing  
5/12/2014Larry N FeinbergMajor ShareholderBuy297,618$16.80$4,999,982.40View SEC Filing  
2/5/2014Larry N FeinbergMajor ShareholderBuy8,554$24.78$211,968.12View SEC Filing  
1/27/2014Larry N FeinbergMajor ShareholderBuy16,307$13.09$213,458.63View SEC Filing  
12/31/2013Larry N FeinbergMajor ShareholderBuy84,081$12.29$1,033,355.49View SEC Filing  
10/30/2013Larry N FeinbergMajor ShareholderBuy10,000$12.95$129,500.00View SEC Filing  
8/30/2013Larry N FeinbergMajor ShareholderBuy16,001$9.76$156,169.76View SEC Filing  
8/28/2013Larry N FeinbergMajor ShareholderBuy158,445$9.80$1,552,761.00View SEC Filing  
8/16/2013Jack W SchulerDirectorBuy78,494$7.88$618,532.72View SEC Filing  
8/14/2013Jack W SchulerDirectorBuy413,090$8.04$3,321,243.60View SEC Filing  
8/14/2013Larry N FeinbergMajor ShareholderBuy36,814$7.24$266,533.36View SEC Filing  
8/9/2013Larry N FeinbergMajor ShareholderBuy35,168$7.30$256,726.40View SEC Filing  
6/21/2013Larry N FeinbergMajor ShareholderBuy114,250$8.00$914,000.00View SEC Filing  
6/12/2013Larry N FeinbergMajor ShareholderBuy7,175$8.41$60,341.75View SEC Filing  
6/7/2013Larry N FeinbergMajor ShareholderBuy45,508$8.33$379,081.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Accelerate Diagnostics (NASDAQ:AXDX)
DateHeadline
capitalcube.com logoETF’s with exposure to Accelerate Diagnostics, Inc. : September 19, 2016 (NASDAQ:AXDX)
www.capitalcube.com - September 19 at 4:39 PM
finance.yahoo.com logoAccelerate Diagnostics (AXDX) Enters Overbought Territory (NASDAQ:AXDX)
finance.yahoo.com - September 16 at 3:41 PM
News IconIs Buying Accelerate Diagnostics Inc Here a Winning Strategy? - Chester News (NASDAQ:AXDX)
www.chesterindependent.com - September 15 at 12:35 PM
thestreet.com logo4 Breakout Stocks to Watch (NASDAQ:AXDX)
www.thestreet.com - September 13 at 8:34 AM
News IconConsensus Analyst Opinions for: Summit Materials, Inc. (NYSE:SUM) , Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Times (press release) (NASDAQ:AXDX)
www.wallstreetnews24.com - September 12 at 8:29 AM
News IconStock Gapping Higher Pre-Market: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Post News (NASDAQ:AXDX)
www.kentuckypostnews.com - September 8 at 3:39 PM
News IconAccelerate Diagnostics Inc. (NASDAQ: AXDX) Upgraded to Hold - BNB Daily (blog) (NASDAQ:AXDX)
www.baseball-news-blog.com - September 7 at 11:53 AM
capitalcube.com logoETF’s with exposure to Accelerate Diagnostics, Inc. : September 6, 2016 (NASDAQ:AXDX)
www.capitalcube.com - September 6 at 3:45 PM
capitalcube.com logoETF’s with exposure to Accelerate Diagnostics, Inc. : August 19, 2016 (NASDAQ:AXDX)
www.capitalcube.com - August 19 at 4:21 PM
capitalcube.com logoETF’s with exposure to Accelerate Diagnostics, Inc. : August 19, 2016 (NASDAQ:AXDX)
www.capitalcube.com - August 19 at 4:21 PM
News IconNotable Tuesday Option Activity: AXDX, LE, ENR (NASDAQ:AXDX)
www.stockoptionschannel.com - August 16 at 3:46 PM
finance.yahoo.com logoACCELERATE DIAGNOSTICS, INC Financials (NASDAQ:AXDX)
finance.yahoo.com - August 16 at 3:46 PM
finance.yahoo.com logoACCELERATE DIAGNOSTICS, INC Financials (NASDAQ:AXDX)
finance.yahoo.com - August 16 at 3:46 PM
capitalcube.com logoAccelerate Diagnostics, Inc. :AXDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:AXDX)
www.capitalcube.com - August 12 at 12:20 PM
tradecalls.org logoChartist Inc Ca buys $1279969 stake in Accelerate Diagnostics Inc (AXDX) - Trade Calls (NASDAQ:AXDX)
www.tradecalls.org - August 10 at 8:28 AM
News IconAccelerate Diagnostics Inc. (NASDAQ: AXDX) Target price raised at JPMorgan - BNB Daily (blog) (NASDAQ:AXDX)
www.baseball-news-blog.com - August 10 at 8:28 AM
seekingalpha.com logoAccelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q2 2016 Results - Earnings Call Transcript (NASDAQ:AXDX)
seekingalpha.com - August 9 at 12:33 PM
tradecalls.org logoChartist Inc Ca buys $1,279,969 stake in Accelerate Diagnostics Inc (AXDX) (NASDAQ:AXDX)
www.tradecalls.org - August 9 at 12:33 PM
streetinsider.com logoAccelerate Diagnostics (AXDX) Regulatory Matters in Order; BTIG Affirms at 'Buy' (NASDAQ:AXDX)
www.streetinsider.com - August 9 at 12:33 PM
seekingalpha.com logoAccelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:AXDX)
seekingalpha.com - August 8 at 9:07 PM
sg.finance.yahoo.com logoAccelerate Diagnostics reports 2Q loss (NASDAQ:AXDX)
sg.finance.yahoo.com - August 8 at 9:07 PM
biz.yahoo.com logoQ2 2016 Accelerate Diagnostics Inc Earnings Release - After Market Close (NASDAQ:AXDX)
biz.yahoo.com - August 8 at 8:29 AM
News IconYahoo Finance and AYDX (NASDAQ:AXDX)
www.goerie.com - August 3 at 12:20 PM
News IconBerko: Ditch Yahoo Finance for stock advice; buy AXDX (NASDAQ:AXDX)
www.columbian.com - July 31 at 3:40 PM
News IconTaking Stock: Loyal users find Yahoo Finance has been hijacked by an inferior Yaphooey Finance (NASDAQ:AXDX)
newsok.com - July 31 at 8:37 AM
capitalcube.com logoETF’s with exposure to Accelerate Diagnostics, Inc. : July 26, 2016 (NASDAQ:AXDX)
www.capitalcube.com - July 26 at 11:45 AM
twst.com logoAccelerate Diagnostics Inc. : Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8 - The Wall Street Transcript (NASDAQ:AXDX)
www.twst.com - July 22 at 11:52 AM
publicnow.com logoAccelerate Diagnostics to Report Second-Quarter 2016 Results on August 8 (NASDAQ:AXDX)
www.publicnow.com - July 22 at 8:38 AM
News IconAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Increased By 2.3% - Consumer Eagle (NASDAQ:AXDX)
www.consumereagle.com - July 21 at 9:35 AM
News IconShare Performance Summary for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX)
presstelegraph.com - July 19 at 3:42 PM
kcregister.com logoToday's Hot List: Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Chanticleer (NASDAQ:HOTR), Bluerock Residential ... - KC Register (NASDAQ:AXDX)
www.kcregister.com - July 18 at 3:45 PM
News IconAccelerate Diagnostics Inc Stock Faces Higher Risks Forward After Forming Bearish Double Bottom - Press Telegraph (NASDAQ:AXDX)
presstelegraph.com - July 18 at 3:45 PM
News IconStock in Positive Territory for the Quarter: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily (NASDAQ:AXDX)
www.engelwooddaily.com - July 17 at 3:36 PM
news.cmlviz.com logoAccelerate Diagnostics Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:AXDX)
news.cmlviz.com - July 16 at 10:04 AM
investing.com logo4 Stocks To Watch: ACIA, AXDX, LCI, XNCR (NASDAQ:AXDX)
www.investing.com - July 15 at 2:17 PM
equities.com logoAccelerate Diagnostics Inc. (AXDX) is Trading Higher on Unusual Volume for July 12 - Equities.com (NASDAQ:AXDX)
www.equities.com - July 14 at 12:36 PM
News IconAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Increased By 5.45% - Consumer Eagle (NASDAQ:AXDX)
www.consumereagle.com - July 13 at 11:49 AM
biz.yahoo.com logoACCELERATE DIAGNOSTICS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:AXDX)
biz.yahoo.com - July 13 at 6:02 AM
News IconStock on the Rise for the Quarter: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily (NASDAQ:AXDX)
www.engelwooddaily.com - July 11 at 8:30 AM
News IconStock Performance Rundown on: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX)
presstelegraph.com - July 11 at 8:30 AM
publicnow.com logoAccelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit (NASDAQ:AXDX)
www.publicnow.com - July 11 at 5:23 AM
finance.yahoo.com logo5:12 am Accelerate Diagnostics submits De Novo request for its Accelerate Pheno system and Accelerate PhenoTest for Evaluation of Automatic Class III Designation to the FDA (NASDAQ:AXDX)
finance.yahoo.com - July 11 at 5:12 AM
News IconAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Sellers Increased By 5.45% Their Shorts - Engelwood Daily (NASDAQ:AXDX)
www.engelwooddaily.com - July 10 at 8:27 AM
News IconAccelerate Diagnostics Inc (NASDAQ:AXDX) Institutional Investors Sentiment Change - Engelwood Daily (NASDAQ:AXDX)
www.engelwooddaily.com - July 8 at 8:50 PM
News IconInsiders Increasing Positions in: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX)
presstelegraph.com - July 7 at 3:43 PM
News IconShares Providing Results This Month for Investors: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Telanagana Press (NASDAQ:AXDX)
telanaganapress.com - July 6 at 8:29 AM
equities.com logoAccelerate Diagnostics Inc. (AXDX) Jumps 12.72% on July 04 - Equities.com (NASDAQ:AXDX)
www.equities.com - July 6 at 8:29 AM
News IconShare Performance Recap for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX)
presstelegraph.com - July 5 at 3:40 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead Accelerate Diagnostics, Inc. (AXDX) - Fiscal Standard (NASDAQ:AXDX)
www.fiscalstandard.com - July 4 at 3:39 PM
fxpips.com logoFriday’s Stock Recap: The Big Movers (NASDAQ:AXDX)
www.fxpips.com - July 4 at 8:33 AM

Social

Accelerate Diagnostics (NASDAQ:AXDX) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff